|
SIRT1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.67350047550497E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.01960001447554E-09 |
| Normal-vs-Stage2 |
1.06199999905243E-08 |
| Normal-vs-Stage3 |
4.2379999509734E-10 |
| Normal-vs-Stage4 |
2.85530044052962E-10 |
| Stage1-vs-Stage2 |
2.797000E-01 |
| Stage1-vs-Stage3 |
2.338200E-01 |
| Stage1-vs-Stage4 |
1.064830E-01 |
| Stage2-vs-Stage3 |
8.484600E-01 |
| Stage2-vs-Stage4 |
8.342600E-01 |
| Stage3-vs-Stage4 |
6.547600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.24929980091804E-10 |
| Normal-vs-AfricanAmerican |
8.3008000000051E-05 |
| Normal-vs-Asian |
1.80179999997865E-06 |
| Caucasian-vs-AfricanAmerican |
6.289600E-01 |
| Caucasian-vs-Asian |
1.941050E-01 |
| AfricanAmerican-vs-Asian |
6.712600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.40089947922684E-10 |
| Normal-vs-Female |
1.00690000781611E-09 |
| Male-vs-Female |
3.335000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.77269993023788E-10 |
| Normal-vs-Age(41-60Yrs) |
1.58369983793705E-10 |
| Normal-vs-Age(61-80Yrs) |
2.60059973555826E-10 |
| Normal-vs-Age(81-100Yrs) |
1.516480E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.870400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.137900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.635800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.855800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.284200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.101600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.616400E-01 |
| Classical-VS-Follicular |
3.152200E-04 |
| Classical-VS-Other |
6.672400E-01 |
| Classical-VS-Normal |
6.15530000303011E-08 |
| Tall-VS-Follicular |
2.456600E-01 |
| Tall-VS-Other |
8.826600E-01 |
| Tall-VS-Normal |
4.97019999601278E-08 |
| Follicular-VS-Other |
4.558800E-01 |
| Follicular-VS-Normal |
2.50319764916185E-11 |
| Other-VS-Normal |
1.148120E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.86000112481588E-11 |
| Normal-vs-N1 |
4.96990004705822E-09 |
| N0-vs-N1 |
8.138000E-01 |
|
|
